tradingkey.logo

Nexgel Inc

NXGL
1.270USD
+0.060+4.96%
Close 02/06, 16:00ETQuotes delayed by 15 min
10.34MMarket Cap
LossP/E TTM

Nexgel Inc

1.270
+0.060+4.96%

More Details of Nexgel Inc Company

NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The Company operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.

Nexgel Inc Info

Ticker SymbolNXGL
Company nameNexgel Inc
IPO dateDec 22, 2021
CEOLevy (Adam)
Number of employees19
Security typeOrdinary Share
Fiscal year-endDec 22
Address2150 Cabot Blvd West,
CityLANGHORNE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code19047
Phone12157028550
Websitehttps://nexgel.com/
Ticker SymbolNXGL
IPO dateDec 22, 2021
CEOLevy (Adam)

Company Executives of Nexgel Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Jerome B. Zeldis, M.D., Ph.D.
Dr. Jerome B. Zeldis, M.D., Ph.D.
Independent Director
Independent Director
106.66K
--
Mr. Steven Ciardiello
Mr. Steven Ciardiello
Director
Director
21.74K
--
Mr. Joseph F. (Joe) McGuire
Mr. Joseph F. (Joe) McGuire
Chief Financial Officer
Chief Financial Officer
4.08K
--
Mr. Adam Levy
Mr. Adam Levy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Steven Mark Glassman
Mr. Steven Mark Glassman
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Nachum Stein
Mr. Nachum Stein
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Mr. Scott R. Henry
Mr. Scott R. Henry
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Jerome B. Zeldis, M.D., Ph.D.
Dr. Jerome B. Zeldis, M.D., Ph.D.
Independent Director
Independent Director
106.66K
--
Mr. Steven Ciardiello
Mr. Steven Ciardiello
Director
Director
21.74K
--
Mr. Joseph F. (Joe) McGuire
Mr. Joseph F. (Joe) McGuire
Chief Financial Officer
Chief Financial Officer
4.08K
--
Mr. Adam Levy
Mr. Adam Levy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Steven Mark Glassman
Mr. Steven Mark Glassman
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Nachum Stein
Mr. Nachum Stein
Independent Director
Independent Director
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Stein (John Nachum)
5.67%
Levy (Adam R)
4.61%
Glassman (steven mark)
1.95%
The Vanguard Group, Inc.
1.51%
Henry (Scott Robert)
1.42%
Other
84.85%
Shareholders
Shareholders
Proportion
Stein (John Nachum)
5.67%
Levy (Adam R)
4.61%
Glassman (steven mark)
1.95%
The Vanguard Group, Inc.
1.51%
Henry (Scott Robert)
1.42%
Other
84.85%
Shareholder Types
Shareholders
Proportion
Individual Investor
15.27%
Investment Advisor
3.85%
Investment Advisor/Hedge Fund
1.62%
Hedge Fund
1.12%
Venture Capital
0.16%
Family Office
0.14%
Other
77.84%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
28
550.04K
6.75%
-301.48K
2025Q3
29
790.59K
9.71%
+68.50K
2025Q2
34
1.90M
23.61%
-162.86K
2025Q1
37
2.17M
29.57%
+164.76K
2024Q4
32
1.98M
26.34%
+256.49K
2024Q3
30
1.74M
25.65%
+126.36K
2024Q2
29
1.63M
25.29%
+39.41K
2024Q1
28
1.57M
26.08%
+59.90K
2023Q4
28
1.51M
25.63%
-46.18K
2023Q3
30
1.53M
26.03%
-38.00K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Stein (John Nachum)
461.46K
5.67%
--
--
Oct 20, 2025
Levy (Adam R)
375.15K
4.61%
-10.00K
-2.60%
Dec 24, 2025
Glassman (steven mark)
158.74K
1.95%
+2.08K
+1.33%
Oct 20, 2025
The Vanguard Group, Inc.
123.61K
1.52%
+54.96K
+80.06%
Sep 30, 2025
Henry (Scott Robert)
115.44K
1.42%
-5.92K
-4.87%
Oct 20, 2025
Zeldis (Jerome B)
106.66K
1.31%
--
--
Oct 20, 2025
Morgan Stanley Smith Barney LLC
87.10K
1.07%
-34.45K
-28.34%
Sep 30, 2025
Geode Capital Management, L.L.C.
66.37K
0.81%
--
--
Sep 30, 2025
Renaissance Technologies LLC
63.45K
0.78%
+8.62K
+15.72%
Sep 30, 2025
Susquehanna International Group, LLP
43.63K
0.54%
+43.63K
--
Sep 30, 2025
View more

Related ETFs

Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Dimensional US Core Equity 1 ETF
0%
Dimensional US Core Equity 1 ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI